Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Clinical trial NCT07105228 · COMPLETED

Trial details

NCT number: NCT07105228
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Retinal Vasculitis

Start date: 2025-07-15
Primary completion: 2025-08-30
Enrollment: 290000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.